Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells

Molecular and Cellular Biology

Volumn 24, Issue 22, 2004, Pages 9695-9704

  Fribley, Andrew ^a   Zeng, Qinghua ^a   Wang, Cun Yu ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME INHIBITOR; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOMA CELL; CONTROLLED STUDY; DNA MICROARRAY; ENDOPLASMIC RETICULUM; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STRESS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BORONIC ACIDS; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 7644242953     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.22.9695-9704.2004     Document Type: Article

References (48)

1. Adams, J. 2003. The proteasome: structure, function, and role in the cell. Cancer Treat. Rev. 29(Suppl. 1):3-9.
2. Adams, J., V. J. Palombella, E. A. Sausville, J. Johnson, A. Destree, D. D. Lazarus, J. Mass, C. S. Pien, S. Prakash, and P. J. Elliot. 1999. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 59:2615-2622.
3. Chen, S., A. Fribley, and C.-Y. Wang. 2002. Potentiation of tumor necrosis factor-mediated apoptosis of oral squamous cell carcinoma cells by adenovirus-mediated gene transfer of NF-κB inhibitor. J. Dent. Res. 81:98-102.
4. Fischer, H., U. Koenig, L. Eckhart, and E. Tschachler. 2002. Human caspase 12 has acquired deleterious mutations. Biochem. Biophys. Res. Commun. 293:722-726.
5. Fleming, J. A., E. S. Lightcap, S. Sadis, V. Thoroddsen, C. E. Bulawa, and R. K. Blackman. 2002. Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341. Proc. Natl. Acad. Sci. USA 99:1461-1466.
6. Forastiere, A., W. Koch, A. Trotti, and D. Sidransky. 2001. Head and neck cancer. N. Engl. J. Med. 345:1890-1900.
7. Frankel, A., S. Man, P. Elliott, J. Adams, and R. S. Kerbel. 2000. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Clin. Cancer Res. 6:3719-3728.
8. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109:S81-S96.
9. L prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol. Cell. Biol. 20:5680-5689.
10. Green, D., and J. Reed. 1998. Mitochondria and apoptosis. Science 281: 1309-1312.
11. Harding, H. P., Y. Zhang, H. Zeng, I. Novoa, P. D. Lu, M. Calfon, N. Sadri, C. Yun, P. Popko, R. Paules, D. F. Stojdl, J. C. Bell, T. Hettmann, J. M. Leiden, and D. Ron. 2003. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11:619-633.
12. Hideshima, T., P. Richardson, D. Chauhan, V. J. Palombella, P. J. Elliott, J. Adams, and K. C., Anderson. 2001. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res. 61:3071-3076.
13. Hideshima, T., C. Mitsiades, M. Akiyama, T. Hayashi, D. Chauhan, P. Richardson, R. Schlossman, K. Podar, N. C. Munshi, N. Mitsiades, and K. C. Anderson. 2003. Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341. Blood 101:1530-1534.
14. Huang, T. T., S. M. Wuerzberger-Davis, Z. Wu, and S. Miyamoto. 2003. Sequential modification of NEMO/IKKγ by SUMO-1 and ubiquitin mediates NF-κB activation by genotoxic stress. Cell 115:565-576.
15. Jiang, H., S. A. Wek, B. C. McGrath, D. Lu, T. Hai, H. P. Harding, X. Wang, D. Ron, D. R. Cavener, and R. C. Wek. 2004. Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol. Cell. Biol. 24:1365-1377.
16. Jimbo, A., E. Fujita, Y. Kouroku, J. Ohnishi, N. Inohara, K. Kuida, K. Sakamaki, S. Yonehara, and T. Momoi. 2003. ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation. Exp. Cell Res. 283:156-166.
17. Kaufman, R. J. 2002. Orchestrating the unfolded protein response in health and disease. J. Clin. Investig. 110:1389-1398.
18. Lassus, P., X. Opitz-Araya, and Y. Lazebnik. 2002. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297:1352-1354.
19. Lee, A., N. N. Iwakoshi, and L. H. Glimcher. 2003. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol. Cell. Biol. 23:7448-7459.
20. Li, P., D. Nijhawan, I. Budihardjo, S. Srinivasula, M. Ahmad, E. Alnemri, and X. Wang. 1996. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489.
21. Lin, Y., A. Devin, Y. Rodriguez, and Z. G. Liu. 1999. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13:2514-2526.
22. Lin, A., and M. Karin. 2003. NF-kappaB in cancer: a marked target. Semin. Cancer Biol. 13:107-114.
23. Liu, Z. G., H. Hsu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565-576.
24. Ma, M. H., H. H. Yang, K. Parker, S. Manyak, J. M. Friedman, C. Altamirano, Z. Q. Wu, M. J. Borad, M. Frantzen, E. Roussos, J. Neeser, A. Mikail, J. Adams, N. Sjak-Shie, R. A. Vescio, and J. R. Berenson. 2003. The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents. Clin. Cancer Res. 9:1136-1144.
25. Madrid, L. V., C.-Y. Wang, D. C. Guttridge, A. J. Schottelius, A. S. Baldwin, and M. W. Mayo. 2000. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Mol. Cell. Biol. 20:1626-1638.
26. Maniatis, T. 1999. A ubiquitin ligase complex essential for the NF-κB, Wnt/Wingless, and Hedgehog signaling pathways. Genes Dev. 13:505-510.
27. Mayo, M. W., and A. S. Baldwin. 2000. The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance. Biochim. Biophys. Acta 1470:M55-M62.
28. McCullough, K. D., J. L. Martindale, L. Klotz, T. Aw, and N. J. Holbrook. 2001. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell. Biol. 21:1249-1259.
29. Mitsiades, N., C. S. Mitsiades, V. Poulaki, D. Chauhan, G. Fanourakis, X. Gu, C. Bailey, M. Joseph, T. A. Libermann, S. P. Treon, et al. 2002. Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc. Natl. Acad. Sci. USA 99:14374-14379.
30. Nakagawa, T., H. Zhu, N. Morishima, E. Li, J. Xu, B. Yanker, and J. Yuan. 2000. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403:98-103.
31. Patel, V., C. Leethanakul, and J. S. Gutkind. 2001. New approaches to the understanding of the molecular basis of oral cancer. Crit. Rev. Oral Biol. Med. 12:55-63.
32. Ron, D. 2002. Translational control in the endoplasmic reticulum stress response. J. Clin. Investig. 110:1383-1388.
33. Russo, S. M., J. E. Tepper, A. S. Baldwin, Jr., R. Liu, J. Adams, P. Elliott, and J. C. Cusack. 2001. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-κB. Int. J. Radiat. Oncol. Biol. Phys. 50:183-193.
34. Ryter, S. W., and R. M. Tyrrell. 2000. The heme synthesis and degradation pathways: role in oxidant sensitivity. Free Rad. Biol. Med. 28:289-309.
35. Scheuner, D., B. Song, E. McEwen, C. Liu, R. Laybutt, P. Gillespie, T. Saunders, S. Bonner-Weir, and R. J. Kaufman. 2001. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol. Cell 7:1165-1176.
36. Shintani, S., M. Mihara, Y. Ueyama, T. Matsumura, and D. T. Wong. 2001. Cyclin D1 overexpression associates with radiosensitivity in oral squamous cell carcinoma. Int. J. Cancer 96:159-165.
37. Sunwoo, J. B., Z. Chen, G. Dong, N. Yeh, C. Crowl Bancroft, E. Sausville, J. Adams, P. Elliott, and C. Van Waes. 2001. Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin. Cancer Res. 7:1419-1428.
38. Tergaonkar, V., M. Pando, O. Vafa, G. Wahl, and I. Verma. 2002. p53 stabilization is decreased upon NFκB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. Cancer Cell 1:493-503.
39. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-alpha-induced apoptosis by NF-κB. Science 274: 787-789.
40. Wang, C.-Y., M. Mayo, and A. S. Baldwin. 1996. TNF- and cancer therapy-induced apoptosis potentiation by inhibition of NF-κB. Science 274:784-787.
41. Wang, C.-Y., M. W. Mayo, R. C. Korneluk, D. V. Goeddel, and A. S. Baldwin. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683.
42. Wang, C.-Y., D. C. Guttridge, M. W. Mayo, and A. S. Baldwin. 1999. NF-κB expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol. 19:5923-5929.
43. Wang, C.-Y., J. Cusack, R. Liu, and A. S. Baldwin. 1999. Control of inducible chemoresistance: enhanced anti-tumor therapy via increased apoptosis through inhibition of NF-κB. Nat. Med. 5:412-417.
44. Yamada, J., S. Yoshimura, H. Yamakawa, M. Sawada, M. Nakagawa, S. Hara Y. Kaku, T. Iwama, T. Naganawa, Y. Banno, S. Nakashima, and N. Sakai. 2003. Cell permeable ROS scavengers, Tiron and Tempo1, rescue PC12 cell death caused by pyrogallol or hypoxia/reoxygenation. Neurosci. Res. 45:1-8.
45. Yamaguchi, H., K. Bhalla, and H. G. Wang. 2003. Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria. Cancer Res. 63:1483-1489.
46. Yoshida, H., T. Matsui, A. Yamamoto, T. Okada, and K. Mori. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881-891.
47. Zeng, Q., S. Chen, Z. You, F. Yang, T. E. Carey, D. Saims, and C.-Y. Wang. 2002. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFκB. J. Biol. Chem. 277:25203-25208.
48. Zong, W. X., C. Li, G. Hatzivassiliou, T. Lindsten, Q. C. Yu, J. Yuan, and C. B. Thompson. 2003. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J. Cell Biol. 162:59-69.